相关实验视频

Updated: Jun 10, 2025

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Semi-automatic PD-L1 Characterization and Enumeration of Circulating Tumor Cells from Non-small Cell Lung Cancer Patients by Immunofluorescence

Published on: August 14, 2019

单细胞分析在肺癌免疫治疗中的应用:当前进展,新的挑战和期望

Nan Xiao¹, Hongyang Liu², Chenxing Zhang¹

¹Department of Clinical Laboratory, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.

Journal of advanced research

|October 14, 2024

概括

单细胞分析正在通过绘制免疫细胞和瘤微环境异质性来彻底改变肺癌免疫疗法. 这项技术有助于开发改进的治疗方法和识别非小细胞肺癌 (NSCLC) 的生物标志物.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
基因组学就是基因组学.

背景情况:

肺癌是全球主要的健康问题,包括非小细胞肺癌 (NSCLC) 和小细胞肺癌 (SCLC).
目前的免疫疗法因SCLC进展和NSCLC转移,复发和耐药性而面临挑战.
瘤微环境中的瘤异质性是限制治疗疗效的关键因素.

研究的目的:

审查用于肺癌免疫治疗的单细胞分析的进展.
探索单细胞技术与转录组学,表观组学,基因组学和蛋白质组学的整合.
突出单细胞分析的应用,以了解NSCLC及其瘤微环境.

主要方法:

单细胞测序技术. 单细胞测序技术.
与转录组,表观组,基因组和蛋白质组分析的整合.
在绘制瘤透淋巴细胞和循环瘤细胞的应用.

主要成果:

单细胞分析有效地映射了NSCLC患者的免疫细胞.
增加了循环瘤细胞的识别.
实现了瘤微环境异质性的阐明.

结论:

单细胞分析对于了解肺癌免疫疗法至关重要.
它使免疫细胞命运的表征和治疗策略的改进成为可能.
识别预后生物标志物和提高治疗结果的潜力.

关键词:

免疫治疗是一种免疫疗法.肺癌是一种肺癌.一个单细胞分析.瘤异质性瘤异质性

更多相关视频

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Single-cell Analysis of Immunophenotype and Cytokine Production in Peripheral Whole Blood via Mass Cytometry

Published on: June 26, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.